Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy

Thrombosis and Haemostasis

Volumn 104, Issue 5, 2010, Pages 1049-1054

  Di Nisio, Marcello ^a   Ferrante, Noemi ^a   De Tursi, Michele ^a   Iacobelli, Stefano ^a   Cuccurullo, Franco ^a   Büller, Harry R ^b   Feragalli, Beatrice ^a   Porreca, Ettore ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cancer; Chemotherapy; Venous thrombosis

Indexed keywords

ANTHRACYCLINE; BEVACIZUMAB; BLEOMYCIN; CAPECITABINE; CARBOPLATIN; CETUXIMAB; CYCLOPHOSPHAMIDE; ERLOTINIB; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; LOW MOLECULAR WEIGHT HEPARIN; METHOTREXATE; NAVELBINE; OXALIPLATIN; TOPOTECAN; TRASTUZUMAB;

ADULT; AMBULATORY CARE; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER PATIENT; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; FEMALE; GYNECOLOGIC CANCER; HUMAN; INCIDENTAL FINDING; LEUKOCYTE COUNT; LUNG CANCER; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEOPLASM; OUTCOME ASSESSMENT; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; SPLANCHNIC NERVE; TREATMENT DURATION; UROGENITAL TRACT CANCER; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

AGED; AMBULATORY CARE; ANTICOAGULANTS; ANTINEOPLASTIC AGENTS; CHI-SQUARE DISTRIBUTION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INCIDENCE; INCIDENTAL FINDINGS; ITALY; MALE; MIDDLE AGED; NEOPLASMS; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 78149484216     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-05-0277     Document Type: Article

References (30)

1. Lee AYY, Levine MN. Venous thromboembolism and cancer: risks and outcomes. Circulation 2003; 107: I-17-I-21.
2. Prandoni P, Falanga A, Piccioli A. Cancer and venous thromboembolism. Lancet Oncol 2005; 6: 401-410.
3. Seddighzadeh A, Shetty R, Goldhaber SZ. Venous thromboembolism in patients with active cancer. Thromb Haemost 2007; 98: 656-661.
4. Paneesha S, McManus A, Arya R, et al.; VERITY Investigators. Frequency, demographics and risk (according to tumour type or site) of cancer-associated thrombosis among patients seen at outpatient DVT clinics. Thromb Haemost 2010; 103: 338-343.
5. Sebastian AJ, Paddon AJ. Clinically unsuspected pulmonary embolism-an important secondary finding in oncology CT. Clin Radiol 2006; 61: 81-85.
6. Boswell WD, Pierce J, Fahimi A, et al. Incidental pulmonary emboli detected by multi-detector row spiral CT in cancer patients. Cancer Imag 2004; 4: S58.
7. Gosselin MV, Rubin GD, Leung AN, et al. Unsuspected Pulmonary embolism: prospective detection on routine helical CT Scans. Radiology 1998; 208: 209-215.
8. Gladish GW, Choe DH, Marom EM, et al. Incidental pulmonary emboli in oncology patients: prevalence, CT evaluation, and natural history. Radiology 2006; 240: 246-255.
9. Storto ML, Di Credico A, Guido F, et al. Incidental detection of pulmonary emboli on routine MDCT of the chest. Am J Roentgenol 2005; 184: 264-267.
10. Douma RA, Kok MGM, Verberne LM, et al. Incidental venous thromboembolism in cancer patients: prevalence and consequence. Thromb Res 2010; 125: 306-309.
11. Otten H-M, Mathijssen J, ten Cate H, et al. Symptomatic venous thromboembolism in cancer patients treated with chemotherapy. An underestimated phenomenon. Arch Intern Med 2004; 164: 190-194.
12. Haddad TC, Greeno EW. Chemotherapy-induced thrombosis. Thromb Res 2006; 118: 555-568.
13. Heidrich H, Konau E, Hesse P. Asymptomatic venous thrombosis in cancer patients, a problem often overlooked. Results of a retrospective and prospective study. Vasa 2009; 38: 160-166.
14. nd ed). Berlin, Germany: Spinger-Verlag; 1999.
15. Lyman GH, Khorana AA, Falanga A, et al. American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer. J Clin Oncol 2007; 25: 5490-5505. (Pubitemid 350232226)
16. Dentali F, Ageno W, Becattini C, et al. Prevalence and clinical history of incidental, asymptomatic pulmonary embolism: a meta-analysis. Thromb Res 2010; 125: 518-522.
17. Agnelli G, Gussoni G, Bianchini C, et al. on behalf of the PROTECHT Investigators. Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study. Lancet Oncol 2009; 10: 943-949.
18. O'Connell CL, Boswell WD, Duddalwar V, et al. Unsuspected pulmonary emboli in cancer patients: clinical correlates and relevance. J Clin Oncol 2006; 24: 4928-4932.
19. Khorana AA, Kuderer NM, Culakova E, et al. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 2008; 111: 4902-4907.
20. Chew HK, Wun T, Harvey D, et al. Incidence of venous thromboembolism and its effects on survival among patients with common cancers. Arch Intern Med 2006; 166: 458-464.
21. Blom JW, Doggen CJM, Osanto S, et al. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. J Am Med Assoc 2005; 293: 715-722. (Pubitemid 40216041)
22. Sallah S, Wan JY, Nguyen NP. Venous thrombosis in patients with solid tumors: determination of frequency and characteristics. Thromb Haemost 2002; 87: 575-579.
23. Blom JW, Vanderschoot JP, Oostindier MJ, et al. Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost 2006; 4: 529-535.
24. Trujillo-Santos J, Di Micco P, Iannuzzo M, et al.; RIETE Investigators. Elevated white blood cell count and outcome in cancer patients with venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost 2008; 100: 905-911.
25. Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 2001; 358: 9-15.
26. Mismetti P, Laporte S, Darmon JY, et al. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 2001; 88: 913-930.
27. Vaitkus PT, Leizorovicz A, Cohen AT, et al. Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients. Thromb Haemost 2005; 93: 76-79.
28. Dentali F, Vitale J, Nitti C, et al. Prognostic relevance of asymptomatic VTE in cancer patients. J Thromb Haemost 2009; 7 (Supplement 2): Abstract.
29. Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 454-545.
30. Engelke C, Rummeny EJ, Marten K. Pulmonary embolism at multi-detector row CT of chest: one year survival of treated and untreated patients. Radiology 2006; 239: 563-575.